CONSOLIDATED STATEMENT OF OPERATIONS (USD $)	12 Months Ended		86 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
Income Statement [Abstract]
REVENUES
COST AND EXPENSES
Research and Development	17,715	51,286	1,272,886
General and Administrative	564,479	779,482	6,899,014
Depreciation and Amortization			2,668
Consulting and Professional Fees	213,232	63,692	5,023,946
Impairment of Goodwill and Intangibles			34,688
Total Costs and Expenses	795,426	894,460	13,233,202
OPERATING LOSS	(795,426)	(894,460)	(13,233,202)
OTHER INCOME & (EXPENSES)
Interest Expense	(55,139)	(62,829)	(413,674)
Loss on Early Extinguishment of Debt	(41,688)		(41,688)
Interest Expense attributable to amortization of discount	(374,338)		(374,338)
Interest Income			306
Securities issued pursuant to contractual obligations	(66,372)		(66,372)
Other Income	25	146,791	176,916
Gain on de-consolidation of subsidiary		41,645,688	41,645,688
Loss on sale of Available for Sale Securities			(487,900)
Loss on disposal of Equipment	20,789	510,780	531,569
Other Expense			(166)
Other Losses attributable to subsidiary
Total Other Income & (Expense)	(558,301)	41,218,868	39,907,201
NET INCOME (LOSS)	(1,353,727)	40,324,408	26,673,999
(Net Income) Loss attributable to noncontrolling interest		229,845	536,961
NET INCOME (LOSS) before equity in losses of Entest	(1,353,727)	40,554,253	27,210,960
Equity in Net Income (Loss) of Entest	(399,082)	(264,567)	(663,649)
NET INCOME (LOSS) attributable to common shareholders	$ (1,752,809)	$ 40,289,686	$ 26,547,311
BASIC AND FULLY DILUTED EARNINGS (LOSS)	$ (0.01)	$ 0.56
Weighted average number of shares outstanding	148,749,547	72,071,414